Global CSR Program 2023: Relief International | Takeda Pharmaceuticals
Providing medical supplies in conflict-affected countries
Training and building capacity of local pharmaceutical and medical device suppliers to support health and humanitarian responses with increasing availability of quality essential medicines and medical supplies
The Program
Partner: Relief International-UK
Budget: 1,146 million yen
Term: 4 years
Launch: 2023
Area: Myanmar, Afghanistan, Syria, Yemen
Visit the Relief International website
In low- and middle-income countries, 1 in 10 medicines are substandard or falsified which can harm patients and erode faith in the health care system. This is especially true in fragile and conflict-affected settings, making the restoration and stabilization of access to health and nutrition services a priority. This program will build local supply chain capacity of 20 local pharmaceutical and medical device suppliers, enabling suppliers to meet internationally recognized quality standards and provide uninterrupted service delivery and increased quality of medicines and supplies in fragile and conflict-affected settings.
Photo Credit: Relief International
Photo Credit: Relief International
Have more questions?
Contact us if you'd like more information about our Global CSR Program.
Banner Image Credit: Relief International